Evidence map›Paper›PMID 37835839›Full record

ArticleDiagnostics (Basel, Switzerland)2023

Analytical Validation of an Immunohistochemical 7-Biomarker Prognostic Assay (immunoprint

Mirjana Ziemer, Beate Weidenthaler-Barth, Philipp Gussek, Maja Pfeiffer, Johannes Kleemann, Katrin Bankov, Peter J Wild, Silke Seibold, Priyavathi Sureshkumar, Patricia Nickel and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Mirjana ZiemerDepartment of Dermatology, Allergology and Venereology, University Medical Center, 04103 Leipzig, Germany.ORCID 0000-0001-6488-1917
Beate Weidenthaler-BarthDepartment of Dermatology, University Medical Center Mainz, 55131 Mainz, Germany.ORCID 0009-0000-3150-1586
Philipp GussekDepartment of Dermatology, Allergology and Venereology, University Medical Center, 04103 Leipzig, Germany.
Maja PfeifferDepartment of Dermatology, University Medical Center Mainz, 55131 Mainz, Germany.
Johannes KleemannDepartment of Dermatology, Venerology and Allergology, University Hospital Frankfurt, Goethe University, 60590 Frankfurt am Main, Germany.ORCID 0000-0002-2005-5282
Katrin BankovDr. Senckenberg Institute of Pathology, University Hospital Frankfurt, Goethe University, 60590 Frankfurt am Main, Germany.ORCID 0009-0005-4033-4966
Peter J WildDr. Senckenberg Institute of Pathology, University Hospital Frankfurt, Goethe University, 60590 Frankfurt am Main, Germany.ORCID 0000-0002-1017-3744
Silke SeiboldSynvie GmbH, 80992 Munich, Germany.
Priyavathi SureshkumarSynvie GmbH, 80992 Munich, Germany.
Patricia NickelSynvie GmbH, 80992 Munich, Germany.
Anton StrobelSynvie GmbH, 80992 Munich, Germany.
Markus WernerSynvie GmbH, 80992 Munich, Germany.
Stephan GrabbeDepartment of Dermatology, University Medical Center Mainz, 55131 Mainz, Germany.ORCID 0000-0002-6863-8719
Goethe University Frankfurt · DEJohannes Gutenberg University Mainz · DE

Funding

Synvie GmbH not applicable (no grant number)
6 · The paper itself

Abstract

Selected patients with early-stage melanoma have a "hidden high risk" of poor oncologic outcomes. They might benefit from clinical trials, and ultimately, if warranted by trial results, judicious everyday use of adjuvant therapy. A promising tool to identify these individuals is the immunoprint

Indexed as

7-marker signature prognostic assay (immunoprint®)analytical validationconcordancecutaneous melanomaimmunohistochemistryreliabilityrepeatabilityreproducibilityrisk stratification

Identifiers

PMID37835839
PMCPMC10572486
OpenAlexW4387259190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.